Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MDA-MB-175-VII
HR+
Luminal
SB-3CT
MMP2/9
MMP
12126.144
uM
inf
inf
0.4468 0.4468 0.0000 0.2552
0.5580
0.6379
21MT-1
HER2amp
-
Dichloroacetate
PDK
PDK
13719.176
uM
inf
inf
0.9233 0.9233 0.0000 0.0596
-0.2426
0.8672
SUM190PT
HER2amp
Luminal
Ribavirin
15358.211
uM
inf
inf
1.0036 1.0036 0.0000 -0.0073
-0.0327
1.3504
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12000.155
uM
inf
inf
0.6675 0.6675 0.0000 0.2919
0.2735
0.8592
HCC1395
TNBC
Basal B
Dactolisib
PI3K
PI3K
12084.155
uM
inf
inf
0.8548 0.8548 0.0000 0.1129
0.4499
1.2955
MCF7
HR+
Luminal
Dichloroacetate
PDK
PDK
12657.176
uM
inf
inf
0.9410 0.9410 0.0000 0.0143
0.5190
1.0711
HCC1395
TNBC
Basal B
Dichloroacetate
PDK
PDK
13538.176
uM
inf
inf
0.8042 0.8042 0.0000 0.1436
0.3146
0.4572
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7475.07
uM
inf
inf
0.4928 0.4928 0.0000 0.0421
0.3563
2.7378
MDA-MB-134-VI
HR+
Luminal
L-779450
BRAF
MAPK
10519.137
uM
inf
inf
0.7146 0.7146 0.0000 0.0702
0.5660
1.0772
MCF 10A
NM
Basal B
AS-252424
PI3K
PI3K
11056.158
uM
inf
inf
0.3950 0.3950 0.0000 0.0612
0.4274
2.7355
HCC1395
TNBC
Basal B
Doxorubicin
TOP2
TOP
7816.007
uM
inf
inf
0.3187 0.3187 0.0000 0.2775
0.3760
1.1536
HCC1395
TNBC
Basal B
Epirubicin
TOP2
TOP
7816.017
uM
inf
inf
0.6386 0.6386 0.0000 0.2394
0.3980
1.2318
HCC2185
TNBC
Luminal
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7464.095
uM
inf
inf
0.9059 0.9059 0.0000 -0.0281
-0.2886
0.5464
MDA-MB-157
TNBC
Basal B
MG-132
Proteasome
Proteasome
14218.189
uM
inf
inf
-0.3389 -0.3389 0.0000 0.6358
0.5723
1.3111
MDA-MB-436
TNBC
Basal B
5-FU
TYMS
TYMS
7900.017
uM
inf
inf
-0.7673 -0.7673 0.0000 0.4436
0.5715
0.5383
MDA-MB-415
HR+
Luminal
Dichloroacetate
PDK
PDK
12959.176
uM
inf
inf
0.7219 0.7219 0.0000 0.2500
-1.1239
0.5779
BT-20
TNBC
Basal A
Pertuzumab
5903.102
mg/ml
inf
inf
0.9324 0.9324 0.0000 -0.0074
-0.0405
1.2557
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7884.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6074
HCC2185
TNBC
Luminal
PD184352
MEK
MAPK
12192.155
uM
inf
inf
0.7159 0.7159 0.0000 0.2130
0.0390
0.7451
MDA-MB-361
HER2amp
Luminal
Cetuximab
EGFR
ErbB
7895.018
uM
inf
inf
0.9756 0.9756 0.0000 0.0240
-0.0375
1.2916
HCC70
TNBC
Basal A
FTase Inhibitor I
Ftase
MAPK
12400.167
uM
inf
inf
1.0329 1.0329 0.0000 0.0088
0.0000
1.2627
HCC1395
TNBC
Basal B
FTase Inhibitor I
Ftase
MAPK
12000.167
uM
inf
inf
0.7814 0.7814 0.0000 0.1511
-0.0746
0.7185
SUM225CWN
HER2amp
Basal A
Celecoxib
COX2
COX
10579.136
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6876
SUM225CWN
HER2amp
Basal A
Chk2 inhibitor II
CHK2
CHK
10579.14
uM
inf
inf
0.6784 0.6784 0.0000 0.0743
0.2850
0.9303
SUM225CWN
HER2amp
Basal A
Dactolisib
PI3K
PI3K
12098.155
uM
inf
inf
0.5885 0.5885 0.0000 0.3880
0.4982
1.0503